Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Ferrari Cavalcade Suspended After High-Speed Crash in Argentina Involving a Purosangue- Grasping the Basics of Business Land Regulation
- An Extended time of Self-Reflection: Self-awareness through Journaling
- JW Marriott Tokyo: an elegant retreat amid whirlwind of the city
- Colorado residents face earliest water restrictions ever — a harbinger of worse to come
- Creative Do-It-Yourself Ventures for Each Expertise Level
- Fundamental Home Exercise center Hardware: Amplify Your Exercises
- The Development of Shipping: Controlling Towards a More Associated Future
- Figure out How to Improve Your Stream Voyage with Remarkable Trips and Exercises
